baber/WOPTO huggingface dataset:
Patent CA-2868416-A1 (CA)
Title: Immediate release pharmaceutical compositions with abuse deterrent properties
Inventor: DIEZI THOMAS A
IPC: A61K9/20
Filed: 2013-04-18
Abstract: The present disclosure provides pharmaceutical compositions and processes for making solid dosage form pharmaceutical compositions that provide immediate release of active ingredients and have abuse deterrent properties. The pharmaceutical compositions provided herein comprise at least one pharmaceutically active ingredient, at least one low molecular weight water-soluble polymer, at least one polyglycol, at least one polysaccharide, at least one clay mineral, and, optionally, an effervescent system.
Patent CA-2869532-A1 (CA)
Title: Potato storage
Inventor: TERRY LEON A
IPC: A23B7/148
Filed: 2013-04-19
Abstract: A method of storing potatoes, the method comprising the steps of: providing a plurality of endodormant or ecodormant potatoes; in a first storage step storing the potatoes in a first gaseous environment including carbon dioxide in an amount of from greater than the amount of carbon dioxide present in atmospheric air to up to 5 mol % based on the composition of the first gaseous environment; and in a second subsequent storage step storing the potatoes in a second gaseous environment including carbon dioxide in an amount of from 0.03 to 2 mol % based on the composition of the second gaseous environment, the first and second gaseous environments having different carbon dioxide contents. There is also disclosed a method of storing potatoes, the method comprising the steps of; providing a plurality of endodormant or ecodormant potatoes; in a first storage step storing the plurality of potatoes in a first gaseous environment including carbon dioxide; monitoring the dormancy of the potatoes; in response to eye movement of at least one of the potatoes, changing the first gaseous environment to a second gaseous environment including carbon dioxide; and in a second storage step storing the plurality of potatoes in the second gaseous environment and maintaining a level of carbon dioxide in the second gaseous environment below a selected threshold to control the sugar content of the potatoes.
Patent CA-2871017-A1 (CA)
Title: A delayed release drug formulation
Inventor: BRAVO GONZALEZ ROBERTO CARLOS
IPC: A61K9/28
Filed: 2013-04-29
Abstract: Delayed release of a drug to the colon is achieved from a delayed release formulation comprising a core and a coating for the core. The core comprises a drug and the coating comprises an outer layer and at least one layer between the core and the outer layer selected from the group consisting of an isolation layer and an inner layer. The outer layer comprises a mixture of a first polymeric material which is susceptible to attack by colonic bacteria, and a second polymeric material which has a pH threshold at about pH 5 or above. The inner layer comprises a third polymeric material which is soluble in intestinal fluid or gastrointestinal fluid, said third polymeric material being selected from an at least partially neutralised polycarboxylic acid and a non-ionic polymer. In embodiments in which the third polymeric material is a non-ionic polymer, the inner layer comprises at least one of a buffer agent and a base. The isolation layer comprises a non-ionic polymer which is soluble in intestinal fluid or gastrointestinal fluid. The outer is applied directly to the inner layer or the isolation layer using a coating preparation formed by combining the first polymeric material in an aqueous medium with a second polymeric material in an organic medium. Advantages of formulations according to the present invention include accelerated release of the drug when exposed to colonic conditions and reduction or elimination of a food and/or alcohol effect on drug release after administration.
Patent CA-2872872-A1 (CA)
Inventor: BILODEAU JEAN-FRANCOIS
IPC: G01N33/483
Filed: 2013-05-16
Abstract: The present invention relates to an early predictive marker of pre-eclampsia (PE). The present invention also relates to an assay and diagnostic kit for performing a method of predicting PE by measuring the level of this marker. In particular, the method determines the level a class VI isoprostane in a maternal sample prior to the appearance of symptoms of PE.
Patent CA-2872933-A1 (CA)
Inventor: HITCHCOCK MARION
IPC: A61P35/00
Filed: 2013-05-08
Abstract: Compounds of formula (I), processes for their production and their use as Bubl kinase inhibitors for the treatment of hyperproliferative diseases and/or disorders responsive to induction of cell death.
Patent CA-2879174-A1 (CA)
Inventor: LUEBKE CHARLES JOHN
IPC: G01R31/50
Filed: 2013-09-10
Abstract: A power circuit configured to generate and distribute DC electrical power, the power circuit includes a photovoltaic (PV) system that includes an array of PV modules electrically coupled to a combiner box, and an inverter positioned to receive DC electrical power from the array of PV modules and output AC electrical power. The PV system also includes a signal generator coupled to a first portion of the PV system, and a signal detector coupled to a second portion of the PV system, the signal detector configured to detect secondary signals generated at a loose connection of an electrical joint in the PV system, wherein the secondary signals result from a signal generated by the signal generator.
Patent CA-2879521-A1 (CA)
Title: Valve actuator for rotary valve
Inventor: JACKSON TRENTON FRANK
IPC: F15B15/06
Filed: 2013-07-23
Abstract: A valve actuator for a rotary valve includes a piston (70) and housing assembly (74), wherein axial movement of the piston along a bore of the housing causes an actuator rod (76) to twist or rotate about an axis of the bore. The rotary motion of the actuator rod is caused in some arrangements by axial rotation of the piston along a helical housing wall (82) and/or by axial rotation of a generally helical shape of the actuator rod engaged with a central opening (80) through the piston.
Patent CA-2880991-A1 (CA)
Inventor: DEELEY GEOFFREY THOMAS
IPC: E04C2/32
Filed: 2008-01-24
Abstract: A sheet of cold rolled material having on both of its surfaces rows of projections and rows of depressions, the projections on one surface corresponding with the depressions on the other surface, the relative positions of the projections and depressions being such that lines drawn on a surface of the sheet between adjacent rows of projections are non-rectilinear, the sheet having a base gauge G, wherein each projection has a substantially continuous region of peak plastic strain at, toward or about its apex and/or is thinned by no more than 25% of its base gauge G. Methods of forming the sheet material and tools for forming the sheet material are disclosed.
Patent CA-2881904-A1 (CA)
Inventor: ZHAO PENG
IPC: C22C38/26
Filed: 2013-08-21
Abstract: Disclosed is a super high toughness and high strength drill rod having mass content percentages of: C: 0.24-0.30%, Si: 0.1-0.5%, Mn: 0.7-1.5%, Cr: 0.7-1.5%, Mo: 0.5-0.75%, V: 0.01-0.10%, Nb: 0.01-0.05%, P=0.015%, S=0.005%, and the balance being Fe and inevitable impurities. The manufacturing process of the drill rod is that of: heating the whole drill rod body of the above-mentioned components to 900-950°C, then carrying out axial flow water spray cooling in the inner surface of the drill rod and laminar flow water spray cooling on the outer surface of the drill rod, at the same time controlling different water spray amounts at the thickened end of the tube and the tube body of the drill rod, and then tempering at 650-675°C, so as to obtain a super high toughness and high strength drill rod having a strength of 135 ksi and longitudinal full-size impact toughness =100 J at -20°C.
Patent CA-2882875-A1 (CA)
Title: Reducing the reproductive capacity of mammals
Inventor: MAYER LORRETTA P
IPC: A61P15/00
Filed: 2013-08-23
Abstract: Provided are compositions and methods for reducing the reproductive capacity of mammals. The compositions and methods involve the use and administration of (a) a diterpenoid epoxide comprising a triptolide skeleton and which causes ovarian follicle depletion in female mammals and (b) an organic diepoxide which causes ovarian follicle depletion in female mammals.
Patent CA-2883552-A1 (CA)
Inventor: FORTIN JACQUES
IPC: A47C7/00
Filed: 2015-02-26
Abstract: A self-reclining chair having a variable geometry frame, made of resilient flexible material, and comprising a flexible arch seat panel mounted over a flexible arch support frame in combination with a variable tension mechanism producing a spring load that pulls back the seat in a reclining motion when the tension is released. The seat panel is having spaces of air, cut-out openings made in the arch curvature to accentuate the flexibility. The chair is fitted with a crank handle and a knob to a pre-set pressure of a stopper engagement allowing the chair to stay in a desired seating position. This apparatus provides adjustment for a seat back angle, a seat curvature and auto-pivoting of a leg-rest panel. The seat panel further extends to coincide with the leg-rest panel hinged at a junction with the arch seat panel.
Patent CA-2883701-A1 (CA)
Title: Systeme et procede de prevision d'attrition de la clientele au moyen de donnees dynamiques d'interaction des utilisateurs
Inventor: ZHANG WEN
IPC: G06Q10/06
Filed: 2013-08-30
Abstract: La présente invention concerne un procédé, un système et un support non transitoire lisible par ordinateur permettant de prévoir l'attrition de la clientèle. Le procédé peut inclure l'exécution d'un code pour charger des données d'historique liées à un client dans une base de données afin de créer un fichier récapitulatif de l'historique du client. Le procédé peut inclure l'exécution d'un code pour charger des données journalières liées au client dans un moteur de notation. Le procédé peut inclure le traitement par programmation, via le moteur de notation, d'au moins soit les données d'historique, soit les données journalières pour produire un score d'attrition. Le score d'attrition peut indiquer un signal prédictif de l'attrition du client.
Patent CA-2883894-A1 (CA)
Inventor: LIN JACK
IPC: A61K31/52
Filed: 2013-09-05
Abstract: L'invention concerne des composés actifs sur les protéine kinases c-kit ou les protéine kinases c-kit mutantes ayant des mutations quelconques, ainsi que des procédés de préparation et d'utilisation de ces composés pour traiter des maladies et des affections associées à une activité aberrante des protéine kinases c-kit et des protéine kinases c-kit mutantes.
Patent CA-2887186-A1 (CA)
Inventor: CHAJI GHOLAMREZA
IPC: H01L25/00
Filed: 2015-05-12
Abstract: Post-processing steps for integrating of micro devices into system (receiver) substrate or improving the performance of the micro devices after transfer. Post processing steps for additional structures such as reflective layers, fillers, black matrix or other layers may be used to improve the out coupling or confining of the generated LED light. Dielectric and metallic layers may be used to integrate an electro-optical thin film device into the system substrate with transferred micro devices. Color conversion layers may be integrated into the system substrate to create different outputs from the micro devices.
Patent CA-2888778-A1 (CA)
Title: Suppository insertion device, suppository, and method of manufacturing a suppository
Inventor: ENSIGN JENNIFER D
IPC: A61M31/00
Filed: 2013-10-18
Abstract: Today's suppositories are typically packaged individually for digital administration into the anal canal of a patient. A suppository applicator described herein, which works with individually packaged suppositories, can alternatively be shipped in a prepackaged operational arrangement with a suppository to enable the patient to administer the suppository through use of the applicator in a single operation after opening a hygienic wrapper containing the applicator-suppository combination. A method for manufacturing a suppository includes manufacturing the suppository in the presence of and in contact with an element configured to be used to insert the suppository into a body cavity. The method may include using the element to define a shape of the suppository during the manufacturing. The resulting applicator-suppository combination is more hygienic and easier to handle than the separate applicator and suppository and provides more efficiency from time of opening the packaging to time of commencing administration of the suppository.
Patent CA-2889862-A1 (CA)
Inventor: KURIHARA TAKAO
IPC: C12Q1/68
Filed: 2013-11-05
Abstract: Methods of barcoding nucleic acids, such as genomic DNA, are provided herein. In some embodiments, a fragment of genomic DNA may comprise a first and a second barcode.
Patent CA-2893782-A1 (CA)
Inventor: MATHUR NIPUN
IPC: G06Q50/30
Filed: 2014-01-08
Abstract: A social networking system selects advertisements for presentation to its users on third-party websites. The social networking system receives a request for content from a widget or plug-in on the third-party website and provides content including one or more advertisements for presentation along with content from the third-party website. The third- party website may use revenue generated from users accessing advertisements presented via the social networking system to supplement or eliminate revenue from typical banner ads.
Patent CA-2894530-A1 (CA)
Inventor: HANSEN ROGER
IPC: A63C17/01
Filed: 2013-12-27
Abstract: A device for limiting rotation of a wheel, such as a wheel on a skateboard, comprising a physical stop secured against one wheel of the skateboard. Multiple physical locks may be used, each secured against single wheel. The physical stop may comprise a block of resilient material placed in a semi-compressed state into the gap between the skateboard deck and the wheel such that the block exerts pressure on the wheel sufficient to prevent the wheel from freely rotating. Alternately, the physical stop may comprise a holder at least partially surrounding the wheel and at least one protrusion from the holder adjacent a rolling surface of the wheel, where the protrusion is capable of functioning as a chock and substantially preventing the wheel from rolling against a surface.
Patent CA-2894766-A1 (CA)
Inventor: LESLIE ERIN SCOTT
IPC: A43B23/25
Filed: 2014-06-05
Abstract: An article for footwear that prevents a wearer's foot from slipping out of the footwear is disclosed herein. The footwear article of the present invention also provides aesthetic changes to the footwear to allow matching of different outfit and dress occasions.
Patent CA-2895636-A1 (CA)
Inventor: O'CALLAGHAN JOHN
IPC: C02F1/06
Filed: 2013-12-30
Abstract: The present invention relates to a method and an arrangement for pressure and temperature let down of autoclave discharge slurry (106), in particular in pressure oxidation or high pressure acid leach of metal containing ore. The method of the invention comprises a step of providing autoclave vent gas (105) obtained from the autoclave (1) to the top-entry flash vessel (2) for inducing overpressure to the said top-entry flash vessel and preventing boiling of the slurry during the transfer to next top-entry flash vessel (3). The invention further relates to an autoclave and pressure let-down arrangement adapted for providing autoclave vent gas to one or more top-entry flash vessels.
Patent CA-2896447-A1 (CA)
Title: Electric lighting devices using air flow to generate a flickering flame effect
Inventor: THOMPSON JEFF
IPC: F21S10/04
Filed: 2013-10-16
Abstract: Lighting devices are described having a fan or other means to move air within the device to thereby cause movement of a flame element to simulate the movement of a real flame. In some embodiments, one or more scent cartridges can be disposed within the devices so that the air exiting the devices can be scented. Preferably, the devices include an air conduit to direct the air against the flame element and thereby increase the efficiency of the devices.
Patent CA-2897897-A1 (CA)
Inventor: BEKER TUVIA
IPC: G16H10/60
Filed: 2014-01-14
Abstract: Il est décrit un procédé et un système de données médicales servant à déterminer la pharmacompatibilité d'un sujet. Le système comprend une unité de données pour la génération et le stockage de modules représentant des dossiers médicaux de patients et de patientes. Chaque module comprend une pluralité d'éléments de module, chacun représentant un paramètre médicalement pertinent d'un patient ou d'une patiente, chaque élément étant attribué un identificateur précis dans le module, ainsi qu'une valeur numérique correspondant au paramètre médicalement pertinent. Le système comprend également une unité de traitement pour l'exécution de logiciel autodidacte pour construire un modèle à partir des caractéristiques statistiques non étiquetées de données historiques des patients et des patientes, et pour la comparaison informatique de valeurs d'au moins une partie des éléments d'un module du sujet au modèle pour déterminer la pharmacompatibilité du sujet.
Patent CA-2899280-A1 (CA)
Inventor: BORDES PHILIPPE
IPC: H04N19/30
Filed: 2014-02-17
Abstract: A method for decoding a picture block is disclosed. The decoding method comprises: - decoding (10) at least one stream S_diff into decoded data and into one information for identifying a reconstructed reference picture in a decoder picture buffer; - reconstructing (12) a special reference picture from at least the identified reconstructed reference picture and from the decoded data; - reconstructing (16) the picture block from at least the special reference picture, wherein the at least the special reference picture is not displayed.
Patent CA-2899540-A1 (CA)
Title: Audio encoders, audio decoders, systems, methods and computer programs using an increased temporal resolution in temporal proximity of onsets or offsets of fricatives or affricates
Inventor: DISCH SASCHA
IPC: G10L19/025
Filed: 2014-01-28
Abstract: An audio encoder for providing an encoded audio information on the basis of an input audio information comprises a bandwidth extension information provider configured to provide bandwidth extension information using a variab!e temporal resolution and a detector configured to detect an onset of a fricative or affricate. The audio encoder is configured to adjust a temporal resolution used by the bandwidth extension information provider such that bandwidth extension information is provided with an increased temporal resolution at least for a predetermined period of time before a time at which an onset of a fricative or affricate is detected and for a predetermined period of time following the time at which the onset of the fricative or affricate is detected. Alternatively or in addition, the bandwidth extension information is provided with an increased temporal resolution in response to a detection of an offset of a fricative or affricate. Audio encoders and methods use a corresponding concept.
Patent CA-2900064-A1 (CA)
Inventor: LARNICOL MAIWENN TIFENN SOAZIG
IPC: C21D9/46
Filed: 2013-02-06
Abstract: Method of treatment of a running ferrous alloy sheet containing at least one easily oxidized element, comprising a step of immersion of said sheet in a molten oxides bath, wherein: - said molten oxides bath has a viscosity between 0.3.10-3 Pa.s and 3.10-1 Pa.s, the surface of said bath being in contact with a non-oxidizing atmosphere, and said molten oxides are inert towards iron; - the residence time of said running sheet in said bath is at least 1 s; - the residues of oxides remaining on the surfaces of said sheet at the exit of the bath are eliminated. Treatment line of a ferrous alloy sheet (1 ) for implementing said method, comprising : - a molten oxides bath (6) having a viscosity between 0.3.10-3 and 3.10-1 Pa.s, the surface of said bath (6) being in contact with a non-oxidizing atmosphere, said molten oxides being inert towards iron and - means for eliminating the residues of molten oxides remaining on the surfaces of said ferrous alloy sheet (1) at the exit of said molten oxides bath (6).
Patent CA-2900533-A1 (CA)
Inventor: TESSLER SHOSHI
IPC: A61K31/7052
Filed: 2014-03-12
Abstract: The present invention provides a method of treating cancer in a subject afflicted with cancer comprising administering to the subject an anti-clusterin oligonucleotide as a monotherapy to treat the cancer. The present invention also provides compositions for treating cancer in a subject afflicted with cancer, comprising an anti-clusterin oligonucleotide having the sequence CAGCAGCAGAGTCTTCATCAT (Seq. ID No. : 1). Additionally, the present invention provides provides pharmaceutical compositions for treating cancer in a subject afflicted with cancer, the composition comprising an anti- clusterin oligonucleotide having the sequence CAGCAGCAGAGTCTTCATCAT (Seq. ID No. : 1), wherein the anti- clusterin oligonucleotide has a phosphorothioate backbone throughout, has sugar moieties of nucleotides 1-4 and 18-21 bearing 2 ' -O-methoxyethyl modifications, has nucleotides 5-17 which are 2 ' deoxynucleotides, and has 5-methylcytosines at nucleotides 1, 4, and 19.
Patent CA-2901323-A1 (CA)
Title: Formulations of water-soluble derivatives of vitamin e and compositions containing same
Inventor: BROMLEY PHILIP J
IPC: A23L33/15
Filed: 2014-03-12
Abstract: Provided herein are compositions that contain water-soluble vitamin E derivative mixtures (compositions), such as tocopheryl polyethylene glycol succinate (TPGS), TPGS analogs, TPGS homo logs and TPGS derivatives. The water-soluble vitamin E mixtures contain mixtures of dimers and monomers of the vitamin E derivative. Also provided are products containing the water-soluble vitamin E derivative mixtures, including concentrates for dilution into aqueous beverages and compositions for direct ingestion.
Patent CA-2903992-A1 (CA)
Inventor: SURYANARAYANAN DEEPAK
IPC: G06F9/46
Filed: 2014-03-04
Abstract: Systems and methods are presented for accessing an application available from a data center of a program execution service. The metadata associated with a user computing device may be used to determine whether the user computing device is authorized to access the application through a virtual desktop instance. At least a portion of the application may be executed by the virtual desktop instance and provided to the user. Applications may be purchased, licensed, or rented by a user.
Patent CA-2908254-A1 (CA)
Inventor: DOWNS RONALD K
IPC: A61N5/06
Filed: 2014-03-26
Abstract: L'invention porte sur un dispositif de traitement de douleur portable, lequel dispositif comprend une partie de base ayant une première pluralité de dispositifs émetteurs de lumière et une première unité de chauffage sur une surface inférieure, une partie supérieure positionnée sur l'extrémité de la partie de base opposée à la surface inférieure, la partie de base comprenant une ouverture, une seconde pluralité de dispositifs émetteurs de lumière et une seconde unité de chauffage positionnées sur une surface interne de l'ouverture, et une unité de commande configurée de façon à commander l'intensité de lumière des première et seconde pluralités de dispositifs émetteurs de lumière et l'intensité de chaleur des première et seconde unités de chauffage.